Search for dissertations about: "hcv predictors"

Found 4 swedish dissertations containing the words hcv predictors.

  1. 1. On the outcome of antiviral therapy for hepatitis C virus genotype 2 or 3 infection

    Author : Åsa Alsiö; Göteborgs universitet; []
    Keywords : infectious diseases; virology; hepatitis c; treatment;

    Abstract : Abstract Approximately 80% of patients infected with HCV genotypes 2 or 3 achieve a sustained virological response (SVR), following 24 weeks of therapy with ribavirin and pegylated interferon (peg-IFN), but in light of considerable side effects and cost, shortened treatment duration without impaired efficacy is desirable. Thus, 382 genotype 2/3 infected patients were randomized in an investigator-initiated phase III study (NORDynamIC) evaluating the efficacy of 12 (short-term) vs. READ MORE

  2. 2. Immunological and Genetic Markers Predicting Treatment Outcome in Hepatitits C Virus Infection

    Author : Galia Askarieh; Göteborgs universitet; []
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; IP-10; CXCL10; CD26; hepatitis C virus; interferon; ribavirin; treatment; IL28B;

    Abstract : Hepatitis C is a blood-borne infection caused by the hepatitis C virus (HCV). A chronic infection, which develops in most infected subjects, may lead to liver cirrhosis with ensuing liver dysfunction and liver cancer. READ MORE

  3. 3. Risk of hepatocellular carcinoma, liver-related complications, and death in persons living with chronic hepatitis B and D

    Author : Habiba Kamal; Karolinska Institutet; Karolinska Institutet; []
    Keywords : ;

    Abstract : Chronic hepatitis B virus (HBV) infection affects 257 million individuals and is a leading cause of liver-related morbidity and mortality. Hepatitis D virus (HDV) is a satellite virus, that needs HBV for packing and propagation, hence infecting only individuals with HBV infection. READ MORE

  4. 4. A clinical epidemiological study on end-stage liver disease in Ghana

    Author : Yvonne Ayerki Nartey; Karolinska Institutet; Karolinska Institutet; []
    Keywords : ;

    Abstract : End-stage liver disease (ESLD), including advanced liver cirrhosis and hepatocellular carcinoma (HCC), is the final stage of long-standing injury to the liver due to risk factors such as chronic viral hepatitis and alcoholic liver disease. There is a high disease burden and mortality globally, especially in sub-Saharan African (SSA) countries such as Ghana, where the primary cause of HCC and cirrhosis is infection with hepatitis B virus (HBV). READ MORE